Case series of intravenous ketamine infusion in patients with suicidal thought
Suicide is the fourth leading cause of death. The annual global prevalence of suicidal ideas in adult population is 2%. Antidepressants are considered to be the first line of treatment for depression but the maximum response is noted only after 4–6 weeks. However, adding ketamine has shown very rapi...
Main Authors: | Pankaj Sharma, Amresh Dubey, Deven Gajbhiye, Arti Sharma, Akhilesh Kant |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Industrial Psychiatry Journal |
Subjects: | |
Online Access: | http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2023;volume=32;issue=2;spage=437;epage=440;aulast=Sharma |
Similar Items
-
Intravenous ketamine for depression: A clinical discussion reconsidering best practices in acute hypertension management
by: Ryan Yip, et al.
Published: (2022-09-01) -
A Randomized Clinical Trial of Intravenous and Intramuscular Ketamine for Pediatric Procedural Sedation and Analgesia
by: Mohammad Gharavifard, et al.
Published: (2018-12-01) -
Dexmedetomidine/propofol versus dexmedetomidine/ketamine versus dexmedetomidine as a sole agent for pediatric sedation during MRI
by: Mostafa K. Abdellatif, et al.
Published: (2019-02-01) -
Low-dose ketamine infusion for labor analgesia: A double-blind, randomized, placebo controlled clinical trial
by: Sam Joel, et al.
Published: (2014-01-01) -
Effect of magnesium sulfate with ketamine infusions on intraoperative and postoperative analgesia in cancer breast surgeries: a randomized double-blind trial
by: Mohamed Elsayed Hassan, et al.
Published: (2023-03-01)